Holy Stone Healthcare Co., Ltd. (TPEX:4194)
Taiwan · Delayed Price · Currency is TWD 6.95
+0.68 (10.85%)
Aug 26, 2026, 1:59 PM CST
Holy Stone Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| - | - | 118.77 | 236.89 | 270.24 | 217.08 | |
Revenue Growth | - | - | -49.86% | -12.34% | 24.49% | -2.04% |
Cost of Revenue | - | - | 85.91 | 137.51 | 146.97 | 115.26 |
Gross Profit | - | - | 32.86 | 99.38 | 123.28 | 101.83 |
Selling, General & Admin | 17.32 | 19.45 | 48.51 | 89.42 | 93.87 | 84.04 |
Research & Development | 114.86 | 126.14 | 174.16 | 298.26 | 179.38 | 187.6 |
Operating Expenses | 132.18 | 145.58 | 222.68 | 387.99 | 272.23 | 277.29 |
Operating Income | -132.18 | -145.58 | -189.82 | -288.6 | -148.95 | -175.46 |
Interest Expense | -0.24 | -0.26 | -0.64 | -0.63 | -0.43 | -0.51 |
Interest & Investment Income | 1.83 | 2.78 | 3.31 | 2.51 | 2.51 | 0.84 |
Currency Exchange Gain (Loss) | 1.05 | 0.31 | 0.42 | 1.27 | -2.27 | -2.96 |
Other Non Operating Income (Expenses) | 3.53 | 31.43 | 3.26 | 1.03 | 2.71 | 1.95 |
EBT Excluding Unusual Items | -126 | -111.32 | -183.47 | -284.42 | -146.44 | -176.14 |
Pretax Income | -126 | -111.32 | -183.47 | -284.42 | -146.44 | -176.14 |
Income Tax Expense | 0.03 | 0.03 | 0.03 | 4.95 | 6.51 | 5.17 |
Net Income | -126.03 | -111.35 | -183.49 | -289.37 | -152.94 | -181.31 |
Net Income to Common | -126.03 | -111.35 | -183.49 | -289.37 | -152.94 | -181.31 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 146 | 146 | 142 | 137 | 119 | 109 |
Shares Outstanding (Diluted) | 146 | 146 | 142 | 137 | 119 | 109 |
Shares Change | -0.02% | 2.97% | 3.76% | 14.79% | 9.39% | - |
EPS (Basic) | -0.86 | -0.76 | -1.29 | -2.12 | -1.29 | -1.67 |
EPS (Diluted) | -0.86 | -0.76 | -1.29 | -2.12 | -1.29 | -1.67 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -121.73 | -116.41 | -144.76 | -280.82 | -148.09 | -142.16 |
Free Cash Flow Per Share | -0.83 | -0.80 | -1.02 | -2.06 | -1.24 | -1.31 |
Gross Margin | - | - | 27.67% | 41.95% | 45.62% | 46.91% |
Operating Margin | - | - | -159.83% | -121.83% | -55.12% | -80.83% |
Profit Margin | - | - | -154.50% | -122.15% | -56.59% | -83.52% |
Free Cash Flow Margin | - | - | -121.88% | -118.55% | -54.80% | -65.48% |
EBITDA | -125.48 | -139 | -183.59 | -280.09 | -140.64 | -166.44 |
EBITDA Margin | - | - | -154.59% | -118.24% | -52.04% | -76.67% |
D&A For EBITDA | 6.7 | 6.57 | 6.23 | 8.51 | 8.31 | 9.02 |
EBIT | -132.18 | -145.58 | -189.82 | -288.6 | -148.95 | -175.46 |
EBIT Margin | - | - | -159.83% | -121.83% | -55.12% | -80.83% |